Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Relationship between the respiratory microbiome and the severity of airflow limitation, history of exacerbations and circulating eosinophils in COPD patients.

Millares L, Pascual S, Montón C, García-Núñez M, Lalmolda C, Faner R, Casadevall C, Setó L, Capilla S, Moreno A, Castro-Acosta AA, Alvarez-Martinez CJ, Sibila O, Peces-Barba G, Cosio BG, Agustí A, Gea J, Monsó E.

BMC Pulm Med. 2019 Jun 24;19(1):112. doi: 10.1186/s12890-019-0867-x.

2.

The BIOMEPOC Project: Personalized Biomarkers and Clinical Profiles in Chronic Obstructive Pulmonary Disease.

Gea J, Pascual S, Castro-Acosta A, Hernández-Carcereny C, Castelo R, Márquez-Martín E, Montón C, Palou A, Faner R, Furlong LI, Seijo L, Sanz F, Torà M, Vilaplana C, Casadevall C, López-Campos JL, Monsó E, Peces-Barba G, Cosío BG, Agustí A; en representación del grupo BIOMEPOC; Anexo. Miembros del grupo BIOMEPOC.

Arch Bronconeumol. 2019 Feb;55(2):93-99. doi: 10.1016/j.arbres.2018.07.026. Epub 2018 Oct 19. English, Spanish.

3.

Predictors of one-year mortality after hospitalization for an exacerbation of COPD.

Esteban C, Castro-Acosta A, Alvarez-Martínez CJ, Capelastegui A, López-Campos JL, Pozo-Rodriguez F.

BMC Pulm Med. 2018 Jan 25;18(1):18. doi: 10.1186/s12890-018-0574-z.

4.

Accuracy of COPD Diagnosis During an Admission: The European Perspective.

Lopez-Campos JL, Castro-Acosta A, Pozo-Rodriguez F, Hartl S, Roberts CM.

Chest. 2017 Jun;151(6):1396-1397. doi: 10.1016/j.chest.2017.01.044. No abstract available.

PMID:
28599931
5.

Understanding variation in length of hospital stay for COPD exacerbation: European COPD audit.

Ruparel M, López-Campos JL, Castro-Acosta A, Hartl S, Pozo-Rodriguez F, Roberts CM.

ERJ Open Res. 2016 Mar 5;2(1). pii: 00034-2015. eCollection 2016 Jan.

6.

Risk of death and readmission of hospital-admitted COPD exacerbations: European COPD Audit.

Hartl S, Lopez-Campos JL, Pozo-Rodriguez F, Castro-Acosta A, Studnicka M, Kaiser B, Roberts CM.

Eur Respir J. 2016 Jan;47(1):113-21. doi: 10.1183/13993003.01391-2014. Epub 2015 Oct 22.

7.

Clinical audit: why, where and how?

Pozo-Rodríguez F, Castro-Acosta AA, Álvarez-Martínez CJ.

Arch Bronconeumol. 2015 Oct;51(10):479-80. doi: 10.1016/j.arbres.2015.05.006. Epub 2015 Aug 12. English, Spanish. No abstract available.

8.

Molecular and clinical diseasome of comorbidities in exacerbated COPD patients.

Faner R, Gutiérrez-Sacristán A, Castro-Acosta A, Grosdidier S, Gan W, Sánchez-Mayor M, Lopez-Campos JL, Pozo-Rodriguez F, Sanz F, Mannino D, Furlong LI, Agusti A.

Eur Respir J. 2015 Oct;46(4):1001-10. doi: 10.1183/13993003.00763-2015. Epub 2015 Aug 6.

9.

Determinants of between-hospital variations in outcomes for patients admitted with COPD exacerbations: findings from a nationwide clinical audit (AUDIPOC) in Spain.

Pozo-Rodríguez F, Castro-Acosta A, Alvarez CJ, López-Campos JL, Forte A, López-Quilez A, Agustí A, Abraira V; AUDIPOC Study Group.

Int J Clin Pract. 2015 Sep;69(9):938-47. doi: 10.1111/ijcp.12601. Epub 2015 Feb 4.

10.

Results from an audit feedback strategy for chronic obstructive pulmonary disease in-hospital care: a joint analysis from the AUDIPOC and European COPD audit studies.

Lopez-Campos JL, Asensio-Cruz MI, Castro-Acosta A, Calero C, Pozo-Rodriguez F; AUDIPOC and the European COPD Audit studies.

PLoS One. 2014 Oct 15;9(10):e110394. doi: 10.1371/journal.pone.0110394. eCollection 2014.

11.

Predictive factors of severe multilobar pneumonia and shock in patients with influenza.

Garcia Gutierrez S, Quintana JM, Baricot M, Bilbao A, Capelastegui A, Cilla Eguiluz CG, Domínguez A, Castilla J, Godoy P, Delgado-Rodríguez M, Soldevila N, Astray J, Mayoral JM, Martín V, González-Candelas F, Galán JC, Tamames S, Castro-Acosta AA, Garín O, Pumarola T; CIBERESP Cases and Controls in Pandemic Influenza Working Group, Spain.

Emerg Med J. 2014 Apr;31(4):301-7. doi: 10.1136/emermed-2012-202081. Epub 2013 Feb 28.

PMID:
23449891
12.

Clinical audit of COPD patients requiring hospital admissions in Spain: AUDIPOC study.

Pozo-Rodríguez F, López-Campos JL, Alvarez-Martínez CJ, Castro-Acosta A, Agüero R, Hueto J, Hernández-Hernández J, Barrón M, Abraira V, Forte A, Sanchez Nieto JM, Lopez-Gabaldón E, Cosío BG, Agustí A; AUDIPOC Study Group.

PLoS One. 2012;7(7):e42156. Epub 2012 Jul 31.

13.

[Clinical audit of patients admitted to hospital in Spain due to exacerbation of COPD (AUDIPOC study): method and organisation].

Pozo-Rodríguez F, Alvarez CJ, Castro-Acosta A, Melero Moreno C, Capelastegui A, Esteban C, Hernández Carcereny C, López-Campos JL, Izquierdo Alonso JL, López Quílez A, Agustí A; por el Grupo AUDIPOC España.

Arch Bronconeumol. 2010 Jul;46(7):349-57. doi: 10.1016/j.arbres.2010.04.004. Epub 2010 May 31. Spanish.

Supplemental Content

Loading ...
Support Center